(Q52021863)

English

Long lasting p53-specific T cell memory responses in the absence of anti-p53 antibodies in patients with resected primary colorectal cancer.

scientific article published in January 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/11169448

Long lasting p53-specific T cell memory responses in the absence of anti-p53 antibodies in patients with resected primary colorectal cancer. (English)

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/11169448

colorectal cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Kees L M C Franken

4

object named as

Franken KL

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/11169448

author name string

van der Burg SH

1

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/11169448

de Cock K

2

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/11169448

Menon AG

3

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/11169448

Palmen M

5

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/11169448

Redeker A

6

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/11169448

Drijfhout J

7

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/11169448

Kuppen PJ

8

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/11169448

van de Velde C

9

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/11169448

Erdile L

10

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/11169448

Tollenaar RA

11

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/11169448

Melief CJ

12

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/11169448

Offringa R

13

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/11169448

language of work or name

0 references

publication date

1 January 2001

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/11169448

European Journal of Immunology

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/11169448

31

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/11169448

1

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/11169448

146-155

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/11169448

p53 in colorectal cancer: clinicopathological correlation and prognostic significance

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200101%2931%3A1%3C146%3A%3AAID-IMMU146%3E3.0.CO%3B2-T

21 January 2018

p53 immunoreaction in endoscopic biopsy specimens of colorectal cancer, and its prognostic significance

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200101%2931%3A1%3C146%3A%3AAID-IMMU146%3E3.0.CO%3B2-T

21 January 2018

Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200101%2931%3A1%3C146%3A%3AAID-IMMU146%3E3.0.CO%3B2-T

21 January 2018

p53 as a target for cancer vaccines: recombinant canarypox virus vectors expressing p53 protect mice against lethal tumor cell challenge.

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200101%2931%3A1%3C146%3A%3AAID-IMMU146%3E3.0.CO%3B2-T

21 January 2018

In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild-type p53.

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200101%2931%3A1%3C146%3A%3AAID-IMMU146%3E3.0.CO%3B2-T

21 January 2018

Cytotoxic T-lymphocyte clones, established by stimulation with the HLA-A2 binding p5365-73 wild type peptide loaded on dendritic cells In vitro, specifically recognize and lyse HLA-A2 tumour cells overexpressing the p53 protein

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200101%2931%3A1%3C146%3A%3AAID-IMMU146%3E3.0.CO%3B2-T

21 January 2018

Spontaneous human squamous cell carcinomas are killed by a human cytotoxic T lymphocyte clone recognizing a wild-type p53-derived peptide

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200101%2931%3A1%3C146%3A%3AAID-IMMU146%3E3.0.CO%3B2-T

21 January 2018

Evidence that HLA class II-restricted human CD4+ T cells specific to p53 self peptides respond to p53 proteins of both wild and mutant forms

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200101%2931%3A1%3C146%3A%3AAID-IMMU146%3E3.0.CO%3B2-T

21 January 2018

Antibodies against p53 protein in serum of patients with benign or malignant pancreatic and biliary diseases.

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200101%2931%3A1%3C146%3A%3AAID-IMMU146%3E3.0.CO%3B2-T

21 January 2018

Antibodies against p53 are associated with poor prognosis of colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200101%2931%3A1%3C146%3A%3AAID-IMMU146%3E3.0.CO%3B2-T

21 January 2018

Increased serum p53 antibody levels indicate poor prognosis in patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200101%2931%3A1%3C146%3A%3AAID-IMMU146%3E3.0.CO%3B2-T

21 January 2018

Regulation of Ig Class Secretion by Soluble Products of Certain T-Cell Lines

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200101%2931%3A1%3C146%3A%3AAID-IMMU146%3E3.0.CO%3B2-T

21 January 2018

Cross-tolerance: a pathway for inducing tolerance to peripheral tissue antigens

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200101%2931%3A1%3C146%3A%3AAID-IMMU146%3E3.0.CO%3B2-T

21 January 2018

CD4+ T-cell subsets in autoimmunity

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200101%2931%3A1%3C146%3A%3AAID-IMMU146%3E3.0.CO%3B2-T

21 January 2018

Strategies for immunotherapy of cancer

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200101%2931%3A1%3C146%3A%3AAID-IMMU146%3E3.0.CO%3B2-T

21 January 2018

Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200101%2931%3A1%3C146%3A%3AAID-IMMU146%3E3.0.CO%3B2-T

21 January 2018

Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200101%2931%3A1%3C146%3A%3AAID-IMMU146%3E3.0.CO%3B2-T

21 January 2018

Dendritic cell/macrophage precursors capture exogenous antigen for MHC class I presentation by dendritic cells.

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200101%2931%3A1%3C146%3A%3AAID-IMMU146%3E3.0.CO%3B2-T

21 January 2018

Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy.

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200101%2931%3A1%3C146%3A%3AAID-IMMU146%3E3.0.CO%3B2-T

21 January 2018

CD4+ T cell responses to self- and mutated p53 determinants during tumorigenesis in mice

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200101%2931%3A1%3C146%3A%3AAID-IMMU146%3E3.0.CO%3B2-T

21 January 2018

Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200101%2931%3A1%3C146%3A%3AAID-IMMU146%3E3.0.CO%3B2-T

21 January 2018

Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200101%2931%3A1%3C146%3A%3AAID-IMMU146%3E3.0.CO%3B2-T

21 January 2018

Prognostic significance of cytoplasmic p53 overexpression in colorectal cancer. An immunohistochemical analysis

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200101%2931%3A1%3C146%3A%3AAID-IMMU146%3E3.0.CO%3B2-T

21 January 2018

Dendritic cells transduced with wild-type p53 gene elicit potent anti-tumour immune responses

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200101%2931%3A1%3C146%3A%3AAID-IMMU146%3E3.0.CO%3B2-T

21 January 2018

Serum p53 antibodies as early markers of lung cancer

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200101%2931%3A1%3C146%3A%3AAID-IMMU146%3E3.0.CO%3B2-T

21 January 2018

Analysis of p53 serum antibodies in patients with head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200101%2931%3A1%3C146%3A%3AAID-IMMU146%3E3.0.CO%3B2-T

21 January 2018

Primary proliferative T cell response to wild-type p53 protein in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200101%2931%3A1%3C146%3A%3AAID-IMMU146%3E3.0.CO%3B2-T

21 January 2018

T-cell reactivity to beta-cell membrane antigens associated with beta-cell destruction in IDDM

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200101%2931%3A1%3C146%3A%3AAID-IMMU146%3E3.0.CO%3B2-T

21 January 2018

Breakdown of Tolerance to a Neo-Self Antigen in Double Transgenic Mice in Which B Cells Present the Antigen

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200101%2931%3A1%3C146%3A%3AAID-IMMU146%3E3.0.CO%3B2-T

21 January 2018

Class I-restricted presentation of exogenous antigen acquired by Fcγ receptor-mediated endocytosis is regulated in dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200101%2931%3A1%3C146%3A%3AAID-IMMU146%3E3.0.CO%3B2-T

21 January 2018

Purification of his-tagged proteins by immobilized chelate affinity chromatography: the benefits from the use of organic solvent

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200101%2931%3A1%3C146%3A%3AAID-IMMU146%3E3.0.CO%3B2-T

21 January 2018

Identifiers

10.1002/1521-4141(200101)31:1<146::AID-IMMU146>3.0.CO;2-T

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/11169448

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/11169448

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52021863&oldid=2142999364"